Dr. Juan Camilo Arjona Ferreira - 07 Nov 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Issuer symbol
OGN
Transactions as of
07 Nov 2024
Net transactions value
-$36,340
Form type
4
Filing time
08 Nov 2024, 16:17:43 UTC
Previous filing
12 Aug 2024
Next filing
02 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +6,446 +85% $0.000000 13,987 07 Nov 2024 Direct
transaction OGN Common Stock Tax liability $36,340 -2,300 -16% $15.80 11,687 07 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -6,446 -33% $0.000000 12,893 07 Nov 2024 Common Stock 6,446 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Organon & Co. common stock.
F2 On November 7, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two installments on November 7, 2025 and November 7, 2026.